Q32 Bio Inc. QTTB
| Analyst |
Entreprise |
Price during analysis |
Target price |
Potential gain |
Publication date |
| Etzer Darout |
BMO Capital |
23.69 $ |
64 $ |
40.31 % |
05/12/2024 |
| Jay Olson |
Oppenheimer |
48.47 $ |
80 $ |
31.53 % |
16/10/2024 |
| Derek Archila |
Wells Fargo |
50.6056 $ |
95 $ |
44.39 % |
11/09/2024 |
| Thomas Smith |
Leerink Partners |
30.2 $ |
54 $ |
23.80 % |
21/05/2024 |
| Jay Olson |
Oppenheimer |
21.48 $ |
50 $ |
28.52 % |
10/04/2024 |
| Christopher Raymond |
Raymond James |
18 $ |
45 $ |
27.00 % |
02/04/2024 |
| Allison Bratzel |
Piper Sandler |
18 $ |
45 $ |
27.00 % |
02/04/2024 |